Abstract Submissions for the 2024 Asia Conference on Lung Cancer Close June 7
The IASLC 2024 Asia Conference on Lung Cancer is set to take place October 17-19, in Hong Kong. Showcase your knowledge on the latest advancements in clinical research, clinical management, and multidisciplinary care for thoracic malignancies by submitting your scientific abstract under one of the following categories:
- Risk Factors, Risk Reduction, and Tobacco Control
- Tumor Biology—Preclinical Biology
- Tumor Biology—Translational Biology
- Screening and Early Detection
- Pulmonology and Staging
- Early-Stage Non-small Cell Lung Cancer
- Pathology and Biomarkers
- Local-Regional Non-small Cell Lung Cancer
- Metastatic Non-small Cell Lung Cancer—Local Therapies
- Metastatic Non-small Cell Lung Cancer—Cytotoxic Therapy
- Metastatic Non-small Cell Lung Cancer—Immunotherapy
- Metastatic Non-small Cell Lung Cancer—Targeted Therapy
- Small Cell Lung Cancer and Neuroendocrine Tumors
- Mesothelioma, Thymoma, and Other Thoracic Tumors
- Multidisciplinary Care: Nursing, Allied Health, and Palliative Care
- Patient Advocacy
- Global Health
The abstract submission deadline is 23:49 Mountain Daylight Time on June 7, 2024. Authors will be notified of acceptance on July 1, and the deadline to register is September 10.
Submit your abstract for ACLC 2024 here.
Register for the 2024 CT Screening Symposium
Don’t miss the 2024 IASLC CT Screening Symposium: Forefront Advances in Lung Cancer Screening, which will take place September 7 during the 2024 World Conference on Lung Cancer in San Diego.
Dedicated to advancing knowledge and practices in lung cancer screening, the symposium offers an opportunity for healthcare professionals to engage in a day-long exploration of cutting-edge technologies and best practices in lung cancer screening. Through live educational presentations, real-time expert discussions, and interactive question-and-answer sessions, participants will delve into key topics such as:
- Implementation of CT Screening Programs: Challenges and Successes
- Integration of Mobile CT Screening
- Equity in Lung Cancer Screening
- Future Directions and Emerging Technologies
Learn more and register today.
Be Part of IASLC History; Contribute to the Association’s 50th Anniversary Time Capsule
Seeing a need for collaboration to address thoracic malignancies, Drs. David T. Carr, Oleg S. Selawry, Lawrence Broder, Clifton Mountain, and George Higgins recruited more than 250 founding members from around the world and organized the first meeting of the International Association for the Study of Lung Cancer in Florence, Italy, in 1974.
Fifty years—and countless scientific advances in lung cancer—later, the IASLC is building a time capsule as part of its anniversary celebration. Be part of IASLC history by contributing your photos, videos, or other IASLC memorabilia to the time capsule here.
